Pomalidomide Archives - Medical Conferences

Pomalidomide may become the first approved therapy for hereditary haemorrhagic telangiectasia

Presented By

Prof. Keith McCrae, Cleveland Clinic, OH, USA

Trial

Phase 2, PATH-HHT

Conference

ASH 2023

Type

Peer-reviewed article

7 February 2024 14:54

Presented By

Dr Christine Chen, Princess Margaret Cancer Centre, University of Toronto, Canada

Trial

MM-003, STOMP

Conference

ASH 2019

Type

Peer-reviewed article

5 March 2020 22:59

Presented By

Prof. Michel Attal, University Institute Cancer Toulouse Oncopole, France

Trial

Phase 3, ICARIA-MM

Conference

EHA 2019

Type

Peer-reviewed article

9 August 2019 20:38

Presented By

Dr Paul G. Richardson, Dana-Farber Cancer Institute/Harvard Medical School, USA

Trial

Phase 2, ICARIA-MM

Conference

ASCO 2019

Type

Peer-reviewed article

15 July 2019 13:53